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background:  Stent thrombosis (ST), a devastating event with multifactorial etiology, is challenging in management. The present study 
aimed to investigate a variety of treatment management strategies and their outcome for patients undergoing percutaneous coronary 
intervention (PCI) for ST. 
methods:  The study included patients who presented with definite ST documented by angiography from 2000 to 2013. Patients were 
stratified according to 3 treatment strategies: implantation of an additional bare metal stent (BMS group), implantation of an additional drug 
eluting stent (DES group) and aspiration or balloon without additional stent (no stent group). 
Results:  The study cohort included 191 patients who presented with ST, including 55.1% of the patients with early ST, 14.3% with late ST 
and 31.6% with very late ST. Overall, 115 (60%) patients had a new stent implantation during the procedure--70 (36%) with a BMS and 45 
(23%) with a DES. Baseline characteristics were different among the 3 groups. Patients treated with BMS had more cardiogenic shock at 
admission vs. those treated with DES or without any additional stent (27.1%, 6.7% and 21.1% respectively, p=0.02). All patients from the 
BMS and DES groups had angiographic success defined by a final residual stenosis < 50% compared with only 90.5% success rate in the 
patients treated without an additional stent (p<0.001). A trend toward higher rates of target vessel revascularization was reported in the 
BMS group compared with the DES or the no stent groups (16.7% vs. 3.1% and 9.6% respectively, p=0.17). The same trend was reported 
for 6-month myocardial infarction (7.3% vs. 0% and 5.9%, p=0.37) and 6-month MACE rates (32.7% vs. 14.3% and 25.4%, p=0.15). 
Nevertheless, there was no difference in the 6-month cardiac death among the 3 groups. 
conclusion:  Among patients undergoing PCI for angiographically documented ST, stent implantation was associated with a higher rate of 
angiographic success compared with balloon angioplasty alone. Our results suggest that use of bare metal stent is associated with higher 
rates of target vessel failure. This study supports the use of DES as the optimal treatment strategy for patients presenting with ST.
